<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459194</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>The Potential of Glucosinolates and Their Hydrolysis Products as Inhibitors of Cytokine Storms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4826</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules29204826</ELocationID><Abstract><AbstractText>A cytokine storm is an intense inflammatory response characterized by the overproduction of proinflammatory cytokines, resulting in tissue damage, and organ dysfunction. Cytokines play a crucial role in various conditions, such as coronavirus disease, in which the immune system becomes overactive and releases excessive levels of cytokines, including interleukins, tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ). This anomalous response often leads to acute respiratory distress syndrome (ARDS), disseminated intravascular coagulation (DIC), and multiple organ injury (MOI). Glucosinolates are plant secondary metabolites predominantly found in <i>Brassica</i> vegetables, but are also present in other species, such as <i>Moringa</i> Adens and <i>Carica papaya</i> L. When catalyzed by the enzyme myrosinase, glucosinolates produce valuable products, including sulforaphane, phenethyl isothiocyanate, 6-(methylsulfinyl) hexyl isothiocyanate, erucin, goitrin, and moringin. These hydrolyzed products regulate proinflammatory cytokine production by inhibiting the nuclear factor kappa-light-chain-enhancer of activated B-cell (NF-κB) signaling pathway and stimulating the nuclear factor erythroid 2-related factor 2 (<i>Nrf2</i>) signaling pathway. This action can alleviate hyperinflammation in infected cells and modulate cytokine storms. In this review, we aimed to examine the potential role of glucosinolates in modulating cytokine storms and reducing inflammation in various conditions, such as coronavirus disease. Overall, we found that glucosinolates and their hydrolysis products can potentially attenuate cytokine production and the onset of cytokine storms in diseased cells. In summary, glucosinolates could be beneficial in regulating cytokine production and preventing complications related to cytokine storms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ochar</LastName><ForeName>Kingsley</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9800-0217</Identifier><AffiliationInfo><Affiliation>Council for Scientific and Industrial Research, Plant Genetic Resources Research Institute, Bunso P.O. Box 7, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Agrobiodiversity Center, National Institute of Agricultural Sciences, Rural Development Administration, Jeonju 54874, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwar</LastName><ForeName>Kanivalan</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5149-4766</Identifier><AffiliationInfo><Affiliation>National Agrobiodiversity Center, National Institute of Agricultural Sciences, Rural Development Administration, Jeonju 54874, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Vadakkemuriyil Divya</ForeName><Initials>VD</Initials><Identifier Source="ORCID">0000-0003-1269-2836</Identifier><AffiliationInfo><Affiliation>Department of Plant Sciences, Central University of Himachal Pradesh, Shahpur Campus, Kangra District, Shahpur 176206, HP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Yun-Jo</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>National Creative Research Laboratory for Ca2+ Signaling Network, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Bo-Keun</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-2295-365X</Identifier><AffiliationInfo><Affiliation>Department of Applied Plant Science, Chonnam National University, Gwangju 61186, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seong-Hoon</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-3244-4266</Identifier><AffiliationInfo><Affiliation>National Agrobiodiversity Center, National Institute of Agricultural Sciences, Rural Development Administration, Jeonju 54874, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005961">Glucosinolates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017879">Isothiocyanates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005961" MajorTopicYN="Y">Glucosinolates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006868" MajorTopicYN="N">Hydrolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017879" MajorTopicYN="N">Isothiocyanates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NF-κB</Keyword><Keyword MajorTopicYN="N">TNF-α</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">enzymatic hydrolysis</Keyword><Keyword MajorTopicYN="N">glucosinolates</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459194</ArticleId><ArticleId IdType="pmc">PMC11510469</ArticleId><ArticleId IdType="doi">10.3390/molecules29204826</ArticleId><ArticleId IdType="pii">molecules29204826</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kany S., Vollrath J.T., Relja B. Cytokines in inflammatory disease. Int. J. Mol. Sci. 2019;20:6008. doi: 10.3390/ijms20236008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20236008</ArticleId><ArticleId IdType="pmc">PMC6929211</ArticleId><ArticleId IdType="pubmed">31795299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisoncik J.R., Korth M.J., Simmons C.P., Farrar J., Martin T.R., Katze M.G. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 2012;76:16–32. doi: 10.1128/MMBR.05015-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.05015-11</ArticleId><ArticleId IdType="pmc">PMC3294426</ArticleId><ArticleId IdType="pubmed">22390970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Rubin L., Peng T., Liu L., Xing X., Lazarovici P., Zheng W. Cytokine storm in COVID-19: From viral infection to immune responses, diagnosis and therapy. Int. J. Biol. Sci. 2022;18:459. doi: 10.7150/ijbs.59272.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59272</ArticleId><ArticleId IdType="pmc">PMC8741849</ArticleId><ArticleId IdType="pubmed">35002503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.A., Ad’hiah A.H. Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19) Cytokine. 2021;148:155702. doi: 10.1016/j.cyto.2021.155702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155702</ArticleId><ArticleId IdType="pmc">PMC8439667</ArticleId><ArticleId IdType="pubmed">34534925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Castejon G., Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 2011;22:189–195. doi: 10.1016/j.cytogfr.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2011.10.001</ArticleId><ArticleId IdType="pmc">PMC3714593</ArticleId><ArticleId IdType="pubmed">22019906</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S.M., Hejazi M.S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., Farahzadi R., Ghasemnejad T. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 2022;19:92. doi: 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinayagam S., Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431. doi: 10.1016/j.lfs.2020.118431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118431</ArticleId><ArticleId IdType="pmc">PMC7490584</ArticleId><ArticleId IdType="pubmed">32946915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Ren L., Zhang L., Zhong J., Xiao Y., Jia Z., Guo L., Yang J., Wang C., Jiang S. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27:883–890. doi: 10.1016/j.chom.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd J.M., Tamil Selvan M., Cowan S., Kao Y.-F., Midkiff C.C., Narayanan S., Ramachandran A., Ritchey J.W., Miller C.A. Clinical and histopathologic features of a feline SARS-CoV-2 infection model are analogous to acute COVID-19 in humans. Viruses. 2021;13:1550. doi: 10.3390/v13081550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081550</ArticleId><ArticleId IdType="pmc">PMC8402899</ArticleId><ArticleId IdType="pubmed">34452415</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi M., Singh P., Bi H.P., Shivanna A., Kavadichanda C., Tripathy S.R., Parthasarathy J., Tota S., Maurya S., Vijayalekshmi V. Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort. Lupus. 2021;30:158–164. doi: 10.1177/0961203320962855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320962855</ArticleId><ArticleId IdType="pubmed">33019877</ArticleId></ArticleIdList></Reference><Reference><Citation>Que Y., Hu C., Wan K., Hu P., Wang R., Luo J., Li T., Ping R., Hu Q., Sun Y. Cytokine release syndrome in COVID-19: A major mechanism of morbidity and mortality. Int. Rev. Immunol. 2022;41:217–230. doi: 10.1080/08830185.2021.1884248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2021.1884248</ArticleId><ArticleId IdType="pmc">PMC7919105</ArticleId><ArticleId IdType="pubmed">33616462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi C., Terpos E., Rosati M., Angel M., Bear J., Stellas D., Karaliota S., Apostolakou F., Bagratuni T., Patseas D. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 2021;36:109504. doi: 10.1016/j.celrep.2021.109504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109504</ArticleId><ArticleId IdType="pmc">PMC8299183</ArticleId><ArticleId IdType="pubmed">34352226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93:250–256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolodnitsky A., Ionov N., Gravel I., Poroikov V. Natural compounds from medicinal plants against COVID-19. Explor. Drug Sci. 2023;1:253–275. doi: 10.37349/eds.2023.00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.37349/eds.2023.00017</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghav A., Khan Z.A., Upadhayay V.K., Tripathi P., Gautam K.A., Mishra B.K., Ahmad J., Jeong G.-B. Mesenchymal stem cell-derived exosomes exhibit promising potential for treating SARS-CoV-2-infected patients. Cells. 2021;10:587. doi: 10.3390/cells10030587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030587</ArticleId><ArticleId IdType="pmc">PMC8001291</ArticleId><ArticleId IdType="pubmed">33799966</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzvetkov N.T., Kirilov K., Matin M., Atanasov A.G. Natural product drug discovery and drug design: Two approaches shaping new pharmaceutical development. Nephrol. Dial. Transplant. 2024;39:375–378. doi: 10.1093/ndt/gfad208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfad208</ArticleId><ArticleId IdType="pubmed">37708048</ArticleId></ArticleIdList></Reference><Reference><Citation>Salam U., Ullah S., Tang Z.-H., Elateeq A.A., Khan Y., Khan J., Khan A., Ali S. Plant metabolomics: An overview of the role of primary and secondary metabolites against different environmental stress factors. Life. 2023;13:706. doi: 10.3390/life13030706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13030706</ArticleId><ArticleId IdType="pmc">PMC10051737</ArticleId><ArticleId IdType="pubmed">36983860</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshi Z.A., Ahmad W., Lukatkin A.S., Javed S.B. From Nature to lab: A review of secondary metabolite biosynthetic pathways, environmental influences, and in vitro approaches. Metabolites. 2023;13:895. doi: 10.3390/metabo13080895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13080895</ArticleId><ArticleId IdType="pmc">PMC10456650</ArticleId><ArticleId IdType="pubmed">37623839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq H., Asif S., Andleeb A., Hano C., Abbasi B.H. Flavonoid production: Current trends in plant metabolic engineering and de novo microbial production. Metabolites. 2023;13:124. doi: 10.3390/metabo13010124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13010124</ArticleId><ArticleId IdType="pmc">PMC9864322</ArticleId><ArticleId IdType="pubmed">36677049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Cai R., Liu Z., Cui H., She Z. Secondary metabolites from mangrove-associated fungi: Source, chemistry and bioactivities. Nat. Prod. Rep. 2022;39:560–595. doi: 10.1039/D1NP00041A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1NP00041A</ArticleId><ArticleId IdType="pubmed">34623363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacker K. The burden of chronic disease. Mayo Clin. Proc. Innov. Qual. Outcomes. 2024;8:112–119. doi: 10.1016/j.mayocpiqo.2023.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2023.08.005</ArticleId><ArticleId IdType="pmc">PMC10830426</ArticleId><ArticleId IdType="pubmed">38304166</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshafie H.S., Camele I., Mohamed A.A. A comprehensive review on the biological, agricultural and pharmaceutical properties of secondary metabolites based-plant origin. Int. J. Mol. Sci. 2023;24:3266. doi: 10.3390/ijms24043266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043266</ArticleId><ArticleId IdType="pmc">PMC9959544</ArticleId><ArticleId IdType="pubmed">36834673</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino M., Martini D., Venturi S., Tucci M., Porrini M., Riso P., Del Bo’ C. An overview of registered clinical trials on glucosinolates and human health: The current situation. Front. Nutr. 2021;8:730906. doi: 10.3389/fnut.2021.730906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.730906</ArticleId><ArticleId IdType="pmc">PMC8578719</ArticleId><ArticleId IdType="pubmed">34778334</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen V.T., Stewart J., Lopez M., Ioannou I., Allais F. Glucosinolates: Natural occurrence, biosynthesis, accessibility, isolation, structures, and biological activities. Molecules. 2020;25:4537. doi: 10.3390/molecules25194537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25194537</ArticleId><ArticleId IdType="pmc">PMC7582585</ArticleId><ArticleId IdType="pubmed">33022970</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto M., López C.J., Simal-Gandara J. Glucosinolates: Molecular structure, breakdown, genetic, bioavailability, properties and healthy and adverse effects. Adv. Food Nutr. Res. 2019;90:305–350.</Citation><ArticleIdList><ArticleId IdType="pubmed">31445598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhee R.T., Suzuki K. The Immunomodulatory Effects of Sulforaphane in Exercise-Induced Inflammation and Oxidative Stress: A Prospective Nutraceutical. Int. J. Mol. Sci. 2024;25:1790. doi: 10.3390/ijms25031790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25031790</ArticleId><ArticleId IdType="pmc">PMC10855658</ArticleId><ArticleId IdType="pubmed">38339067</ArticleId></ArticleIdList></Reference><Reference><Citation>Miękus N., Marszałek K., Podlacha M., Iqbal A., Puchalski C., Świergiel A.H. Health benefits of plant-derived sulfur compounds, glucosinolates, and organosulfur compounds. Molecules. 2020;25:3804. doi: 10.3390/molecules25173804.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25173804</ArticleId><ArticleId IdType="pmc">PMC7503525</ArticleId><ArticleId IdType="pubmed">32825600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhee R.T., Roberts L.A., Ma S., Suzuki K. Organosulfur compounds: A review of their anti-inflammatory effects in human health. Front. Nutr. 2020;7:64. doi: 10.3389/fnut.2020.00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2020.00064</ArticleId><ArticleId IdType="pmc">PMC7280442</ArticleId><ArticleId IdType="pubmed">32582751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahoosh S.R., Shokoohinia Y., Eftekhari M. Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-CoV-2. DARU J. Pharm. Sci. 2022;30:245–252. doi: 10.1007/s40199-022-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40199-022-00435-x</ArticleId><ArticleId IdType="pmc">PMC8809497</ArticleId><ArticleId IdType="pubmed">35112323</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet J., Anto J., Czarlewski W., Haahtela T., Fonseca S., Iaccarino G., Blain H., Vidal A. Cabbage and fermented vegetables. Allergy. 2020;76:735–750. doi: 10.1111/all.14549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14549</ArticleId><ArticleId IdType="pmc">PMC7436771</ArticleId><ArticleId IdType="pubmed">32762135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kwon M.S., Hwang H., Choi H.-S., Lee W., Choi S.-P., Jo H., Hong S.W. A review of the health benefits of kimchi functional compounds and metabolites. Microbiol. Biotechnol. Lett. 2023;51:353–373. doi: 10.48022/mbl.2310.10011.</Citation><ArticleIdList><ArticleId IdType="doi">10.48022/mbl.2310.10011</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K.-Y., Ju J. Korean Functional Foods. CRC Press; Boca Raton, FL, USA: 2018. Kimchi and its health benefits; pp. 43–78.</Citation></Reference><Reference><Citation>Lavefve L., Marasini D., Carbonero F. Microbial ecology of fermented vegetables and non-alcoholic drinks and current knowledge on their impact on human health. Adv. Food Nutr. Res. 2019;87:147–185.</Citation><ArticleIdList><ArticleId IdType="pubmed">30678814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-A., Joung H., Shin S. Dietary pattern, dietary total antioxidant capacity, and dyslipidemia in Korean adults. Nutr. J. 2019;18:37. doi: 10.1186/s12937-019-0459-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-019-0459-x</ArticleId><ArticleId IdType="pmc">PMC6626369</ArticleId><ArticleId IdType="pubmed">31301735</ArticleId></ArticleIdList></Reference><Reference><Citation>Das G., Paramithiotis S., Sivamaruthi B.S., Wijaya C.H., Suharta S., Sanlier N., Shin H.-S., Patra J.K. Traditional fermented foods with anti-aging effect: A concentric review. Food Res. Int. 2020;134:109269. doi: 10.1016/j.foodres.2020.109269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2020.109269</ArticleId><ArticleId IdType="pubmed">32517898</ArticleId></ArticleIdList></Reference><Reference><Citation>An S.-Y., Lee M.S., Jeon J.Y., Ha E.S., Kim T.H., Yoon J.Y., Ok C.-O., Lee H.-K., Hwang W.-S., Choe S.J. Beneficial effects of fresh and fermented kimchi in prediabetic individuals. Ann. Nutr. Metab. 2013;63:111–119. doi: 10.1159/000353583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353583</ArticleId><ArticleId IdType="pubmed">23969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Soundararajan P., Kim J.S. Anti-carcinogenic glucosinolates in cruciferous vegetables and their antagonistic effects on prevention of cancers. Molecules. 2018;23:2983. doi: 10.3390/molecules23112983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23112983</ArticleId><ArticleId IdType="pmc">PMC6278308</ArticleId><ArticleId IdType="pubmed">30445746</ArticleId></ArticleIdList></Reference><Reference><Citation>Maina A., Mureithi M., Kiiru J., Revathi G. Systemic and Mucosal Concentrations of Nine Cytokines Among Individuals with Neisseria gonorrhoeae infection in Nairobi Kenya. AAS Open Res. 2022;5:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10839855</ArticleId><ArticleId IdType="pubmed">38323170</ArticleId></ArticleIdList></Reference><Reference><Citation>Qudus M.S., Tian M., Sirajuddin S., Liu S., Afaq U., Wali M., Liu J., Pan P., Luo Z., Zhang Q. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. J. Med. Virol. 2023;95:e28751. doi: 10.1002/jmv.28751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28751</ArticleId><ArticleId IdType="pubmed">37185833</ArticleId></ArticleIdList></Reference><Reference><Citation>Chams N., Chams S., Badran R., Shams A., Araji A., Raad M., Mukhopadhyay S., Stroberg E., Duval E.J., Barton L.M. COVID-19: A multidisciplinary review. Front. Public Health. 2020;8:383. doi: 10.3389/fpubh.2020.00383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00383</ArticleId><ArticleId IdType="pmc">PMC7403483</ArticleId><ArticleId IdType="pubmed">32850602</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda S.S., Panda D.S., Dixit R. Proceedings of International Conference on Computational Intelligence: ICCI 2021, Online, 27–28 December 2021. Springer; Singapore: 2022. Revolutionary Solutions for Comprehensive Assessment of COVID-19 Pandemic; pp. 183–195.</Citation></Reference><Reference><Citation>Jarczak D., Nierhaus A. Cytokine storm—Definition, causes, and implications. Int. J. Mol. Sci. 2022;23:11740. doi: 10.3390/ijms231911740.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911740</ArticleId><ArticleId IdType="pmc">PMC9570384</ArticleId><ArticleId IdType="pubmed">36233040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of theCytokine Storm’in COVID-19. J. Infect. 2020;80:607–613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatenoud L., Ferran C., Bach J.-F. Superantigens. Springer; Heidelberg, Germany: 1991. The anti-CD3-induced syndrome: A consequence of massive in vivo cell activation; pp. 121–134.</Citation><ArticleIdList><ArticleId IdType="pubmed">1839376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara J.L. Cytokine dysregulation as a mechanism of graft versus host disease. Curr. Opin. Immunol. 1993;5:794–799. doi: 10.1016/0952-7915(93)90139-J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0952-7915(93)90139-J</ArticleId><ArticleId IdType="pubmed">8240742</ArticleId></ArticleIdList></Reference><Reference><Citation>Fara A., Mitrev Z., Rosalia R.A., Assas B.M. Cytokine storm and COVID-19: A chronicle of pro-inflammatory cytokines. Open Biol. 2020;10:200160. doi: 10.1098/rsob.200160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200160</ArticleId><ArticleId IdType="pmc">PMC7536084</ArticleId><ArticleId IdType="pubmed">32961074</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G., Colafrancesco S., Emmi G., Imazio M., Lopalco G., Maggio M.C., Sota J., Dinarello C.A. Interleukin 1α: A comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun. Rev. 2021;20:102763. doi: 10.1016/j.autrev.2021.102763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102763</ArticleId><ArticleId IdType="pubmed">33482337</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Paolo N.C., Shayakhmetov D.M. Interleukin 1α and the inflammatory process. Nat. Immunol. 2016;17:906–913. doi: 10.1038/ni.3503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3503</ArticleId><ArticleId IdType="pmc">PMC5152572</ArticleId><ArticleId IdType="pubmed">27434011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B., Lee Y., Kim E., Kwak A., Ryoo S., Bae S.H., Azam T., Kim S., Dinarello C.A. The interleukin-1α precursor is biologically active and is likely a key alarmin in the IL-1 family of cytokines. Front. Immunol. 2013;4:391. doi: 10.3389/fimmu.2013.00391.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00391</ArticleId><ArticleId IdType="pmc">PMC3834611</ArticleId><ArticleId IdType="pubmed">24312098</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qahtani A.A., Alhamlan F.S., Al-Qahtani A.A. Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: A comprehensive review. Trop. Med. Infect. Dis. 2024;9:13. doi: 10.3390/tropicalmed9010013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed9010013</ArticleId><ArticleId IdType="pmc">PMC10818686</ArticleId><ArticleId IdType="pubmed">38251210</ArticleId></ArticleIdList></Reference><Reference><Citation>Renu K., Subramaniam M.D., Chakraborty R., Myakala H., Iyer M., Bharathi G., Siva K., Vellingiri B., Gopalakrishnan A.V. The role of Interleukin-4 in COVID-19 associated male infertility–A hypothesis. J. Reprod. Immunol. 2020;142:103213. doi: 10.1016/j.jri.2020.103213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2020.103213</ArticleId><ArticleId IdType="pmc">PMC7526609</ArticleId><ArticleId IdType="pubmed">33080435</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.-G., Li J., Zheng L.-J., Han B., Huang F. Interleukin-36 receptor antagonist alleviates airway inflammation in asthma via inhibiting the activation of interleukin-36 pathway. Int. Immunopharmacol. 2020;81:106200. doi: 10.1016/j.intimp.2020.106200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106200</ArticleId><ArticleId IdType="pubmed">32044656</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinchy B., Gunnerås M., Håkansson A., Håkansson L. Production of IL-1Ra by human mononuclear blood cells in vitro: Influence of serum factors. Cytokine. 2006;34:320–330. doi: 10.1016/j.cyto.2006.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2006.06.010</ArticleId><ArticleId IdType="pubmed">16890452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihim S.A., Abubakar S.D., Zian Z., Sasaki T., Saffarioun M., Maleknia S., Azizi G. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment. Front. Immunol. 2022;13:919973. doi: 10.3389/fimmu.2022.919973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.919973</ArticleId><ArticleId IdType="pmc">PMC9410767</ArticleId><ArticleId IdType="pubmed">36032110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplanski G. Interleukin-18: Biological properties and role in disease pathogenesis. Immunol. Rev. 2018;281:138–153. doi: 10.1111/imr.12616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12616</ArticleId><ArticleId IdType="pmc">PMC7165732</ArticleId><ArticleId IdType="pubmed">29247988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello C.A. Overview of the interleukin-1 family of ligands and receptors. Semin. Immunol. 2013;25:389–393. doi: 10.1016/j.smim.2013.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2013.10.001</ArticleId><ArticleId IdType="pubmed">24275600</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaremi S., Asgarzadeh A., Kianfar H., Mohammadnia A., Asghariazar V., Safarzadeh E. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19. Inflamm. Res. 2022;71:923–947. doi: 10.1007/s00011-022-01596-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01596-w</ArticleId><ArticleId IdType="pmc">PMC9243884</ArticleId><ArticleId IdType="pubmed">35751653</ArticleId></ArticleIdList></Reference><Reference><Citation>Queen D., Ediriweera C., Liu L. Function and regulation of IL-36 signaling in inflammatory diseases and cancer development. Front. Cell Dev. Biol. 2019;7:317. doi: 10.3389/fcell.2019.00317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00317</ArticleId><ArticleId IdType="pmc">PMC6904269</ArticleId><ArticleId IdType="pubmed">31867327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.A., Ad’hiah A.H. Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients. Meta Gene. 2022;31:100989. doi: 10.1016/j.mgene.2021.100989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mgene.2021.100989</ArticleId><ArticleId IdType="pmc">PMC8553418</ArticleId><ArticleId IdType="pubmed">34729360</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudloff I., Ung H.K., Dowling J.K., Mansell A., D’Andrea L., Ellisdon A.M., Whisstock J.C., Berger P.J., Nold-Petry C.A., Nold M.F. Parsing the IL-37-mediated suppression of inflammasome function. Cells. 2020;9:178. doi: 10.3390/cells9010178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010178</ArticleId><ArticleId IdType="pmc">PMC7017287</ArticleId><ArticleId IdType="pubmed">31936823</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z., Tao X. Current understanding of IL-37 in human health and disease. Front. Immunol. 2021;12:696605. doi: 10.3389/fimmu.2021.696605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696605</ArticleId><ArticleId IdType="pmc">PMC8267878</ArticleId><ArticleId IdType="pubmed">34248996</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Paula C.B., de Azevedo M.L.V., Nagashima S., Martins A.P.C., Malaquias M.A.S., Miggiolaro A.F.R.d.S., da Silva Motta Júnior J., Avelino G., do Carmo L.A.P., Carstens L.B. IL-4/IL-13 remodeling pathway of COVID-19 lung injury. Sci. Rep. 2020;10:18689. doi: 10.1038/s41598-020-75659-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75659-5</ArticleId><ArticleId IdType="pmc">PMC7596721</ArticleId><ArticleId IdType="pubmed">33122784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesta M.C., Zippoli M., Marsiglia C., Gavioli E.M., Mantelli F., Allegretti M., Balk R.A. The role of interleukin-8 in lung inflammation and injury: Implications for the management of COVID-19 and hyperinflammatory acute respiratory distress syndrome. Front. Pharmacol. 2022;12:808797. doi: 10.3389/fphar.2021.808797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.808797</ArticleId><ArticleId IdType="pmc">PMC8790527</ArticleId><ArticleId IdType="pubmed">35095519</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Liu Y., Xiang J. Synergistic effect of adoptive T-cell therapy and intratumoral interferon γ-inducible protein-10 transgene expression in treatment of established tumors. Cell. Immunol. 2002;217:12–22. doi: 10.1016/S0008-8749(02)00508-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-8749(02)00508-7</ArticleId><ArticleId IdType="pubmed">12425997</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav V., Sharma S., Kumar A., Singh S., Ravichandiran V. Serratiopeptidase Attenuates Lipopolysaccharide-Induced Vascular Inflammation by Inhibiting the Expression of Monocyte Chemoattractant Protein-1. Curr. Issues Mol. Biol. 2023;45:2201–2212. doi: 10.3390/cimb45030142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb45030142</ArticleId><ArticleId IdType="pmc">PMC10047379</ArticleId><ArticleId IdType="pubmed">36975512</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgovanovic D., Song M., Wang L., Zhang Y. Roles of IFN-γ in tumor progression and regression: A review. Biomark. Res. 2020;8:49. doi: 10.1186/s40364-020-00228-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40364-020-00228-x</ArticleId><ArticleId IdType="pmc">PMC7526126</ArticleId><ArticleId IdType="pubmed">33005420</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z., Tian H., Xing J., Tang X., Sheng X., Chi H., Zhan W. Full-length transcriptome sequencing of lymphocytes respond to IFN-γ reveals a Th1-skewed immune response in flounder (Paralichthys olivaceus) Fish Shellfish Immunol. 2023;134:108636. doi: 10.1016/j.fsi.2023.108636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2023.108636</ArticleId><ArticleId IdType="pubmed">36828199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandikattu H.K., Venkateshaiah S.U., Kumar S., Mishra A. IL-15 immunotherapy is a viable strategy for COVID-19. Cytokine Growth Factor Rev. 2020;54:24–31. doi: 10.1016/j.cytogfr.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7537239</ArticleId><ArticleId IdType="pubmed">32536564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilz S.W. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted. Cytokine Growth Factor Rev. 2021;58:49–50. doi: 10.1016/j.cytogfr.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7583616</ArticleId><ArticleId IdType="pubmed">33199178</ArticleId></ArticleIdList></Reference><Reference><Citation>Malahe S.R.K., den Hartog Y., Rietdijk W.J., van Baarle D., de Kuiper R., Reijerkerk D., Ras A.M., Geers D., Diavatopoulos D.A., Messchendorp A.L. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients. Am. J. Transplant. 2023;23:1411–1424. doi: 10.1016/j.ajt.2023.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2023.05.025</ArticleId><ArticleId IdType="pmc">PMC10234364</ArticleId><ArticleId IdType="pubmed">37270109</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Su J. Interleukin-2 family cytokines: An overview of genes, expression, signaling and functional roles in teleost. Dev. Comp. Immunol. 2023;141:104645. doi: 10.1016/j.dci.2023.104645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dci.2023.104645</ArticleId><ArticleId IdType="pubmed">36696924</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazan A. Interleukin-2 level for normal people and COVID-19 infection: Is it our concern is COVID-19 infection or interleukin-2 level before the infection. Eurasian J. Med. Oncol. 2021;5:309. doi: 10.14744/ejmo.2020.67429.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/ejmo.2020.67429</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Tang T.-X., Deng H., Yang X.-P., Tang Z.-H. Interleukin-7 biology and its effects on immune cells: Mediator of generation, differentiation, survival, and homeostasis. Front. Immunol. 2021;12:747324. doi: 10.3389/fimmu.2021.747324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.747324</ArticleId><ArticleId IdType="pmc">PMC8674869</ArticleId><ArticleId IdType="pubmed">34925323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Kumar S. Ten Weeks of COVID-19 Infection in India-Description and Analysis. SSRN 3576320. 2020.  [(accessed on 7 October 2024)].  Available online:  https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3576320.</Citation></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H.A., Byrareddy S.N. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic. Pediatr. Allergy Immunol. 2021;32:17–22. doi: 10.1111/pai.13361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13361</ArticleId><ArticleId IdType="pmc">PMC7887110</ArticleId><ArticleId IdType="pubmed">32897642</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R.-X., Gong H.-Y., Wang X., Sun M.-H., Ji Y.-F., Tan S.-M., Chen J.-M., Shao J.-W., Liao M. Zoonotic Hantaviridae with global public health significance. Viruses. 2023;15:1705. doi: 10.3390/v15081705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15081705</ArticleId><ArticleId IdType="pmc">PMC10459939</ArticleId><ArticleId IdType="pubmed">37632047</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarczak D., Nierhaus A. Management of Dysregulated Immune Response in the Critically Ill. Springer; Berlin/Heidelberg, Germany: 2023. What Is Cytokine Storm? pp. 35–54.</Citation></Reference><Reference><Citation>Vassiliou A.G., Kotanidou A., Dimopoulou I., Orfanos S.E. Endothelial damage in acute respiratory distress syndrome. Int. J. Mol. Sci. 2020;21:8793. doi: 10.3390/ijms21228793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228793</ArticleId><ArticleId IdType="pmc">PMC7699909</ArticleId><ArticleId IdType="pubmed">33233715</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Paassen J., Vos J.S., Hoekstra E.M., Neumann K.M., Boot P.C., Arbous S.M. Corticosteroid use in COVID-19 patients: A systematic review and meta-analysis on clinical outcomes. Crit. Care. 2020;24:696. doi: 10.1186/s13054-020-03400-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03400-9</ArticleId><ArticleId IdType="pmc">PMC7735177</ArticleId><ArticleId IdType="pubmed">33317589</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A., Campochiaro C., Marmiere M., Likhvantsev V., Yavorovskiy A., Dagna L., Landoni G., Zangrillo A., Hajjar L.A. Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: A systematic review and meta-analysis of multicentre, randomized trials. Ann. Intensive Care. 2021;11:152. doi: 10.1186/s13613-021-00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00941-2</ArticleId><ArticleId IdType="pmc">PMC8547720</ArticleId><ArticleId IdType="pubmed">34704175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Shang L., Fan G., Gu X., Xu J., Wang Y., Huang L., Cao B. The efficacy and safety of janus kinase inhibitors for patients with COVID-19: A living systematic review and meta-analysis. Front. Med. 2022;8:800492. doi: 10.3389/fmed.2021.800492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.800492</ArticleId><ArticleId IdType="pmc">PMC8828941</ArticleId><ArticleId IdType="pubmed">35155477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwah S., Wilcock A., Towers R., Costantini M., Bausewein C., Simon S.T., Bendstrup E., Prentice W., Johnson M.J., Currow D.C. Managing the supportive care needs of those affected by COVID-19. Eur. Respir. J. 2020;55:2000815. doi: 10.1183/13993003.00815-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00815-2020</ArticleId><ArticleId IdType="pmc">PMC7144268</ArticleId><ArticleId IdType="pubmed">32269090</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipour Z., Zarezadeh S., Ghotbi-Ravandi A.A. The potential of anti-coronavirus plant secondary metabolites in COVID-19 drug discovery as an alternative to repurposed drugs: A review. Planta Medica. 2023;90:172–203. doi: 10.1055/a-2209-6357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-2209-6357</ArticleId><ArticleId IdType="pubmed">37956978</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Chillón M.T., Carazo-Díaz C., Prieto-Merino D., Zafrilla P., Moreno D.A., Villaño D. Effects of long-term consumption of broccoli sprouts on inflammatory markers in overweight subjects. Clin. Nutr. 2019;38:745–752. doi: 10.1016/j.clnu.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.03.006</ArticleId><ArticleId IdType="pubmed">29573889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang X.-J., Zhang Y.-Y., Xing Y., Yang L., Ni H., Li H.-H. Simultaneous extraction and separation of oil, proteins, and glucosinolates from Moringa oleifera seeds. Food Chem. 2019;300:125162. doi: 10.1016/j.foodchem.2019.125162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2019.125162</ArticleId><ArticleId IdType="pubmed">31325745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetteh O.N.A., Ulrichs C., Huyskens-Keil S., Mewis I., Amaglo N.K., Oduro I.N., Adarkwah C., Obeng-Ofori D., Förster N. Effects of harvest techniques and drying methods on the stability of glucosinolates in Moringa oleifera leaves during post-harvest. Sci. Hortic. 2019;246:998–1004. doi: 10.1016/j.scienta.2018.11.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scienta.2018.11.089</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelli D., Tavecchio M., Falcioni C., Frapolli R., Erba E., Iori R., Rollin P., Barillari J., Manzotti C., Morazzoni P. The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. Biochem. Pharmacol. 2010;79:1141–1148. doi: 10.1016/j.bcp.2009.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2009.12.008</ArticleId><ArticleId IdType="pubmed">20006591</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraga Y., Ara T., Sato N., Akimoto N., Sugiyama K., Suzuki H., Kera K. Metabolic analysis of unripe papaya (Carica papaya L.) to promote its utilization as a functional food. Biosci. Biotechnol. Biochem. 2021;85:1194–1204. doi: 10.1093/bbb/zbab014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bbb/zbab014</ArticleId><ArticleId IdType="pubmed">33704369</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana L.F., Inada A.C., Espirito Santo B.L.S.d., Filiú W.F., Pott A., Alves F.M., Guimarães R.d.C.A., Freitas K.d.C., Hiane P.A. Nutraceutical potential of Carica papaya in metabolic syndrome. Nutrients. 2019;11:1608. doi: 10.3390/nu11071608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11071608</ArticleId><ArticleId IdType="pmc">PMC6682863</ArticleId><ArticleId IdType="pubmed">31315213</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D.J., Pun S., Chaliha M., Scheelings P., O’Hare T. An unusual combination in papaya (Carica papaya): The good (glucosinolates) and the bad (cyanogenic glycosides) J. Food Compos. Anal. 2013;29:82–86. doi: 10.1016/j.jfca.2012.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfca.2012.06.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-H., Ochar K., Iwar K., Lee Y.-J., Kang H.J., Na Y.-W. Variations of Major Glucosinolates in Diverse Chinese Cabbage (Brassica rapa ssp. pekinensis) Germplasm as Analyzed by UPLC-ESI-MS/MS. Int. J. Mol. Sci. 2024;25:4829. doi: 10.3390/ijms25094829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25094829</ArticleId><ArticleId IdType="pmc">PMC11084679</ArticleId><ArticleId IdType="pubmed">38732049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-H., Lee G.-A., Subramanian P., Hahn B.-S. Quantification and Diversity Analyses of Major Glucosinolates in Conserved Chinese Cabbage (Brassica rapa L. ssp. pekinensis) Germplasms. Foods. 2023;12:1243. doi: 10.3390/foods12061243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods12061243</ArticleId><ArticleId IdType="pmc">PMC10048303</ArticleId><ArticleId IdType="pubmed">36981169</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly E.L., Sim M., Travica N., Marx W., Beasy G., Lynch G.S., Bondonno C.P., Lewis J.R., Hodgson J.M., Blekkenhorst L.C. Glucosinolates from cruciferous vegetables and their potential role in chronic disease: Investigating the preclinical and clinical evidence. Front. Pharmacol. 2021;12:767975. doi: 10.3389/fphar.2021.767975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.767975</ArticleId><ArticleId IdType="pmc">PMC8575925</ArticleId><ArticleId IdType="pubmed">34764875</ArticleId></ArticleIdList></Reference><Reference><Citation>Burčul F., Ivana G.M., Mila R., Patrick R., Ivica B. Isothiocyanates: Cholinesterase inhibiting, antioxidant, and anti-inflammatory activity. Enzyme Inhib. Med. Chem. 2018;33:577–582. doi: 10.1080/14756366.2018.1442832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2018.1442832</ArticleId><ArticleId IdType="pmc">PMC6010089</ArticleId><ArticleId IdType="pubmed">29513045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal R.M., Abdull Razis A.F., Mohd Sukri N.S., Perimal E.K., Ahmad H., Patrick R., Djedaini-Pilard F., Mazzon E., Rigaud S. Beneficial health effects of glucosinolates-derived isothiocyanates on cardiovascular and neurodegenerative diseases. Molecules. 2022;27:624. doi: 10.3390/molecules27030624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27030624</ArticleId><ArticleId IdType="pmc">PMC8838317</ArticleId><ArticleId IdType="pubmed">35163897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaffari M. Herbal Remedies for Management of COVID-19 Induced Myocarditis. Suntext Rev. Cardiovasc. Sci. 2021;1:104.</Citation></Reference><Reference><Citation>Sapra L., Bhardwaj A., Azam Z., Madhry D., Verma B., Rathore S., Srivastava R.K. Phytotherapy for treatment of cytokine storm in COVID-19. Front. Biosci.-Landmark. 2021;26:51–75.</Citation><ArticleIdList><ArticleId IdType="pubmed">34027650</ArticleId></ArticleIdList></Reference><Reference><Citation>Savant S., Srinivasan S., Kruthiventi A.K. Potential nutraceuticals for COVID-19. Nutr. Diet. Suppl. 2021;13:25–51. doi: 10.2147/NDS.S294231.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDS.S294231</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet J., Le Moing V., Blain H., Czarlewski W., Zuberbier T., De La Torre R., Lozano N.P., Reynes J., Bedbrook A., Cristol J.-P. Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases. World Allergy Organ. J. 2021;14:100498. doi: 10.1016/j.waojou.2020.100498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2020.100498</ArticleId><ArticleId IdType="pmc">PMC7770975</ArticleId><ArticleId IdType="pubmed">33425204</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacoppo S., Galuppo M., Iori R., De Nicola G.R., Cassata G., Bramanti P., Mazzon E. Protective role of (RS)-glucoraphanin bioactivated with myrosinase in an experimental model of multiple sclerosis. CNS Neurosci. Ther. 2013;19:577–584. doi: 10.1111/cns.12106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12106</ArticleId><ArticleId IdType="pmc">PMC6493569</ArticleId><ArticleId IdType="pubmed">23638842</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve M. Mechanisms underlying biological effects of cruciferous glucosinolate-derived isothiocyanates/indoles: A focus on metabolic syndrome. Front. Nutr. 2020;7:111. doi: 10.3389/fnut.2020.00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2020.00111</ArticleId><ArticleId IdType="pmc">PMC7492599</ArticleId><ArticleId IdType="pubmed">32984393</ArticleId></ArticleIdList></Reference><Reference><Citation>Caglayan B., Kilic E., Dalay A., Altunay S., Tuzcu M., Erten F., Orhan C., Gunal M.Y., Yulug B., Juturu V. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Mol. Biol. Rep. 2019;46:241–250. doi: 10.1007/s11033-018-4465-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-018-4465-4</ArticleId><ArticleId IdType="pubmed">30406889</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi L., Venkatesan R., Kim S.Y. Neuroprotective and anti-inflammatory activities of allyl isothiocyanate through attenuation of JNK/NF-κB/TNF-α signaling. Int. J. Mol. Sci. 2017;18:1423. doi: 10.3390/ijms18071423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18071423</ArticleId><ArticleId IdType="pmc">PMC5535914</ArticleId><ArticleId IdType="pubmed">28671636</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.L., Kong A.-N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010;12:87–97. doi: 10.1208/s12248-009-9162-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-009-9162-8</ArticleId><ArticleId IdType="pmc">PMC2811646</ArticleId><ArticleId IdType="pubmed">20013083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst I.M., Palani K., Esatbeyoglu T., Schwarz K., Rimbach G. Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin, iberin and cheirolin. Pharmacol. Res. 2013;70:155–162. doi: 10.1016/j.phrs.2013.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2013.01.011</ArticleId><ArticleId IdType="pubmed">23403058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparello J., D’Aversa E., Papi C., Gambari L., Grigolo B., Borgatti M., Finotti A., Gambari R. Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein. Phytomedicine. 2021;87:153583. doi: 10.1016/j.phymed.2021.153583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153583</ArticleId><ArticleId IdType="pmc">PMC8095027</ArticleId><ArticleId IdType="pubmed">34033999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaafaru M.S., Razis A.F.A. Bioactive Food Components Activity in Mechanistic Approach. Elsevier; Amsterdam, The Netherlands: 2022. Sulfur compounds; pp. 211–222.</Citation></Reference><Reference><Citation>Tran H.T., Herz C., Ruf P., Stetter R., Lamy E. Human T2R38 bitter taste receptor expression in resting and activated lymphocytes. Front. Immunol. 2018;9:2949. doi: 10.3389/fimmu.2018.02949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02949</ArticleId><ArticleId IdType="pmc">PMC6297872</ArticleId><ArticleId IdType="pubmed">30619309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaafaru M.S., Abd Karim N.A., Enas M.E., Rollin P., Mazzon E., Abdull Razis A.F. Protective effect of glucosinolates hydrolytic products in neurodegenerative diseases (NDDs) Nutrients. 2018;10:580. doi: 10.3390/nu10050580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10050580</ArticleId><ArticleId IdType="pmc">PMC5986460</ArticleId><ArticleId IdType="pubmed">29738500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Zhou H.-J., Sheng J., Su L.-Y., Tian Y. Extraction, structural properties, and bioactivities of Moringa (Moringa oleifera Lam.) isothiocyanates: A review. Food Biosci. 2023;57:103447. doi: 10.1016/j.fbio.2023.103447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fbio.2023.103447</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C.-M., Wang L., Yoo D. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Sci. Rep. 2021;11:13464. doi: 10.1038/s41598-021-92941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92941-2</ArticleId><ArticleId IdType="pmc">PMC8242070</ArticleId><ArticleId IdType="pubmed">34188167</ArticleId></ArticleIdList></Reference><Reference><Citation>Negi G., Kumar A., S Sharma S. Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr. Neurovasc. Res. 2011;8:294–304. doi: 10.2174/156720211798120972.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720211798120972</ArticleId><ArticleId IdType="pubmed">22023613</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., Shen G., Chen C., Gélinas C., Kong A.-N.T. Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells. Oncogene. 2005;24:4486–4495. doi: 10.1038/sj.onc.1208656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1208656</ArticleId><ArticleId IdType="pubmed">15856023</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant T., Uche N., Juric M., Zielonka J., Bai X. Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases. Redox Biol. 2024;70:103077. doi: 10.1016/j.redox.2024.103077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2024.103077</ArticleId><ArticleId IdType="pmc">PMC10877431</ArticleId><ArticleId IdType="pubmed">38359749</ArticleId></ArticleIdList></Reference><Reference><Citation>Deramaudt T.B., Ali M., Vinit S., Bonay M. Sulforaphane reduces intracellular survival of Staphylococcus aureus in macrophages through inhibition of JNK and p38 MAPK-induced inflammation. Int. J. Mol. Med. 2020;45:1927–1941. doi: 10.3892/ijmm.2020.4563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4563</ArticleId><ArticleId IdType="pmc">PMC7169961</ArticleId><ArticleId IdType="pubmed">32323751</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarozzi A., Angeloni C., Malaguti M., Morroni F., Hrelia S., Hrelia P. Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxidative Med. Cell. Longev. 2013;2013:415078. doi: 10.1155/2013/415078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/415078</ArticleId><ArticleId IdType="pmc">PMC3745957</ArticleId><ArticleId IdType="pubmed">23983898</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D., Farahani E., Thyrsted J., Blay-Cadanet J., Herengt A., Idorn M., Hait A., Hernaez B., Knudsen A., Iversen M.B. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat. Commun. 2020;11:4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiser C., Gonul C.P., Olcum M., Genc S. Inhibitory effects of sulforaphane on NLRP3 inflammasome activation. Mol. Immunol. 2021;140:175–185. doi: 10.1016/j.molimm.2021.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.10.014</ArticleId><ArticleId IdType="pubmed">34717147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparello J., Marzaro G., Papi C., Gentili V., Rizzo R., Zurlo M., Scapoli C., Finotti A., Gambari R. Effects of Sulforaphane on SARS-CoV-2 infection and NF-κB dependent expression of genes involved in the COVID-19 ‘cytokine storm’. Int. J. Mol. Med. 2023;52:1–14. doi: 10.3892/ijmm.2023.5279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2023.5279</ArticleId><ArticleId IdType="pmc">PMC10555481</ArticleId><ArticleId IdType="pubmed">37477130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordonez A.A., Bullen C.K., Villabona-Rueda A.F., Thompson E.A., Turner M.L., Merino V.F., Yan Y., Kim J., Davis S.L., Komm O. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun. Biol. 2022;5:242. doi: 10.1038/s42003-022-03189-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03189-z</ArticleId><ArticleId IdType="pmc">PMC8933402</ArticleId><ArticleId IdType="pubmed">35304580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow C.S., Ramachandram D.S., Hasan S.S. Use of sulforaphane in COVID-19: Clinical trials are needed. Mol. Immunol. 2022;145:78–79. doi: 10.1016/j.molimm.2022.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2022.03.001</ArticleId><ArticleId IdType="pmc">PMC8898664</ArticleId><ArticleId IdType="pubmed">35303531</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J., Jia Y. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 2021;12:4664. doi: 10.1038/s41467-021-25015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25015-6</ArticleId><ArticleId IdType="pmc">PMC8329225</ArticleId><ArticleId IdType="pubmed">34341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufekci K.U., Ercan I., Isci K.B., Olcum M., Tastan B., Gonul C.P., Genc K., Genc S. Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunol. Lett. 2021;233:20–30. doi: 10.1016/j.imlet.2021.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2021.03.004</ArticleId><ArticleId IdType="pubmed">33711331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Du R., Cooper L., Achi J.G., Dong M., Ran Y., Zhang J., Zhan P., Rong L., Cui Q. Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2. J. Med. Virol. 2023;95:e28609. doi: 10.1002/jmv.28609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28609</ArticleId><ArticleId IdType="pubmed">36840402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoch C.C., Shoykhet M., Weiser T., Griesbaum L., Petry J., Hachani K., Multhoff G., Dezfouli A.B., Wollenberg B. Isothiocyanates in medicine: A comprehensive review on phenylethyl-, allyl-, and benzyl-isothiocyanates. Pharmacol. Res. 2024;201:107107. doi: 10.1016/j.phrs.2024.107107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2024.107107</ArticleId><ArticleId IdType="pubmed">38354869</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro V., Carpena M., Fraga-Corral M., Lopez-Soria A., Garcia-Perez P., Barral-Martinez M., Perez-Gregorio R., Cao H., Simal-Gandara J., Prieto M. Natural Secondary Metabolites: From Nature, through Science, to Industry. Springer; Berlin/Heidelberg, Germany: 2023. Sulfur-containing compounds from plants; pp. 363–402.</Citation></Reference><Reference><Citation>Sita G., Hrelia P., Tarozzi A., Morroni F. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease. Int. J. Mol. Sci. 2016;17:1454. doi: 10.3390/ijms17091454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17091454</ArticleId><ArticleId IdType="pmc">PMC5037733</ArticleId><ArticleId IdType="pubmed">27598127</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes F., Paredes-Gonzalez X., Kong A.-N.T. Dietary glucosinolates sulforaphane, phenethyl isothiocyanate, indole-3-carbinol/3, 3′-diindolylmethane: Antioxidative stress/inflammation, Nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy. Curr. Pharmacol. Rep. 2015;1:179–196. doi: 10.1007/s40495-015-0017-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40495-015-0017-y</ArticleId><ArticleId IdType="pmc">PMC4596548</ArticleId><ArticleId IdType="pubmed">26457242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez C.N., Li W., Zhang C., Wu R., Su S., Wang C., Gao L., Yin R., Kong A.-N. In vitro-in vivo dose response of ursolic acid, sulforaphane, PEITC, and curcumin in cancer prevention. AAPS J. 2018;20:19. doi: 10.1208/s12248-017-0177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-017-0177-2</ArticleId><ArticleId IdType="pmc">PMC6021020</ArticleId><ArticleId IdType="pubmed">29264822</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskar V., Krishnan M., Rajakumar G., Hariram Nile S., Thiruvengadam M. Modulation of Expression Levels of Various Cytokines and Inflammatory Responses by Glucosinolate Derivatives. Curr. Top. Med. Chem. 2023;23:1575–1578. doi: 10.2174/1568026623666230605120626.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026623666230605120626</ArticleId><ArticleId IdType="pubmed">37282634</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam M.S., Ahmad M.A. Multidisciplinary Applications of Natural Science for Drug Discovery and Integrative Medicine. IGI Global; Pennsylvania, PA, USA: 2023.</Citation></Reference><Reference><Citation>Okamoto T., Akita N., Nagai M., Hayashi T., Suzuki K. 6-Methylsulfinylhexyl isothiocyanate modulates endothelial cell function and suppresses leukocyte adhesion. J. Nat. Med. 2014;68:144–153. doi: 10.1007/s11418-013-0784-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11418-013-0784-x</ArticleId><ArticleId IdType="pubmed">23760613</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Uto T., Tanigawa S., Yamada-Kato T., Fujii M., Hou D.-X. Microarray-based determination of anti-inflammatory genes targeted by 6-(methylsulfinyl) hexyl isothiocyanate in macrophages. Exp. Ther. Med. 2010;1:33–40. doi: 10.3892/etm_00000006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm_00000006</ArticleId><ArticleId IdType="pmc">PMC3490381</ArticleId><ArticleId IdType="pubmed">23136589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi E.H., Suzuki T., Funayama R., Nagashima T., Hayashi M., Sekine H., Tanaka N., Moriguchi T., Motohashi H., Nakayama K. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 2016;7:11624. doi: 10.1038/ncomms11624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11624</ArticleId><ArticleId IdType="pmc">PMC4879264</ArticleId><ArticleId IdType="pubmed">27211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Xie X., Tu Z., Fu J., Xu D., Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther. 2021;6:255. doi: 10.1038/s41392-021-00679-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00679-0</ArticleId><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnotta E., Ugolini L., Matteo R., Righetti L. Bioactive compounds from Eruca sativa seeds. Encyclopedia. 2022;2:1866–1879. doi: 10.3390/encyclopedia2040129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/encyclopedia2040129</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchini A., Traka M.H. Biological profile of erucin: A new promising anticancer agent from cruciferous vegetables. Toxins. 2010;2:593–612. doi: 10.3390/toxins2040593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins2040593</ArticleId><ArticleId IdType="pmc">PMC3153205</ArticleId><ArticleId IdType="pubmed">22069601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner A.E., Sturm C., Piegholdt S., Wolf I.M., Esatbeyoglu T., De Nicola G.R., Iori R., Rimbach G. Myrosinase-treated glucoerucin is a potent inducer of the Nrf2 target gene heme oxygenase 1—Studies in cultured HT-29 cells and mice. J. Nutr. Biochem. 2015;26:661–666. doi: 10.1016/j.jnutbio.2015.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2015.01.004</ArticleId><ArticleId IdType="pubmed">25776458</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresca D.C., Conte L., Romano B., Ianaro A., Ercolano G. Antiproliferative and Proapoptotic Effects of Erucin, a Diet-Derived H2S Donor, on Human Melanoma Cells. Antioxidants. 2022;12:41. doi: 10.3390/antiox12010041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12010041</ArticleId><ArticleId IdType="pmc">PMC9854590</ArticleId><ArticleId IdType="pubmed">36670903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon N. The Chemopreventive Potential of Sulforaphane and Erucin. University of Surrey; Guildford, UK: 2008.</Citation></Reference><Reference><Citation>Genah S., Ciccone V., Filippelli A., Simonis V., Martelli A., Piragine E., Pagnotta E., Pecchioni N., Calderone V., Morbidelli L. Erucin, a natural isothiocyanate, exerts pro-angiogenic properties in cultured endothelial cells and reverts angiogenic impairment induced by high glucose. Phytother. Res. 2024;38:2641–2655. doi: 10.1002/ptr.8183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.8183</ArticleId><ArticleId IdType="pubmed">38488442</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Singh G., Attri S., Kaur P., Rashid F., Bedi N., Haque S., Janahi E.M., Arora S. Development and optimization of nanoparticles loaded with erucin, a dietary isothiocyanate isolated from Eruca sativa: Antioxidant and antiproliferative activities in ehrlich-ascites carcinoma cell line. Front. Pharmacol. 2023;13:1080977. doi: 10.3389/fphar.2022.1080977.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1080977</ArticleId><ArticleId IdType="pmc">PMC9905727</ArticleId><ArticleId IdType="pubmed">36761468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.J., Lee K.W., Park J.H.Y. Erucin exerts anti-inflammatory properties in murine macrophages and mouse skin: Possible mediation through the inhibition of NFκB signaling. Int. J. Mol. Sci. 2013;14:20564–20577. doi: 10.3390/ijms141020564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141020564</ArticleId><ArticleId IdType="pmc">PMC3821631</ArticleId><ArticleId IdType="pubmed">24132147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yehuda H., Soroka Y., Zlotkin-Frušić M., Gilhar A., Milner Y., Tamir S. Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin. Inflamm. Res. 2012;61:735–742. doi: 10.1007/s00011-012-0465-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-012-0465-3</ArticleId><ArticleId IdType="pubmed">22453842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosokawa Y., Hosokawa I., Shimoyama M., Fujii A., Sato J., Kadena K., Ozaki K., Hosaka K. The anti-inflammatory effects of iberin on TNF-α-stimulated human oral epithelial cells: In vitro research. Biomedicines. 2022;10:3155. doi: 10.3390/biomedicines10123155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123155</ArticleId><ArticleId IdType="pmc">PMC9775133</ArticleId><ArticleId IdType="pubmed">36551911</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazumder A., Dwivedi A., Du Plessis J. Sinigrin and its therapeutic benefits. Molecules. 2016;21:416. doi: 10.3390/molecules21040416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules21040416</ArticleId><ArticleId IdType="pmc">PMC6273501</ArticleId><ArticleId IdType="pubmed">27043505</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi L., Lee J.H., Yumnam S., Ji E., Kim S.Y. Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-κB inhibition and Nrf2/HO-1 activation. Cells. 2019;8:194. doi: 10.3390/cells8020194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020194</ArticleId><ArticleId IdType="pmc">PMC6406309</ArticleId><ArticleId IdType="pubmed">30813369</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Chin F.W.L., Huang D., Liu S.-Q., Lu Y. The thermal degradation of glucomoringin and changes of phenolic compounds in moringa seed kernels during different degrees of roasting. Food Chem. 2024;454:139782. doi: 10.1016/j.foodchem.2024.139782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2024.139782</ArticleId><ArticleId IdType="pubmed">38795626</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjunath S.H., Nataraj P., Swamy V.H., Sugur K., Dey S.K., Ranganathan V., Daniel S., Leihang Z., Sharon V., Chandrashekharappa S. Development of Moringa oleifera as functional food targeting NRF2 signaling: Antioxidant and anti-inflammatory activity in experimental model systems. Food Funct. 2023;14:4734–4751. doi: 10.1039/D3FO00572K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3FO00572K</ArticleId><ArticleId IdType="pubmed">37114361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricosta L., Gugliandolo A., Diomede F., Pizzicannella J., Trubiani O., Iori R., Tardiolo G., Guarnieri S., Bramanti P., Mazzon E. Moringin pretreatment inhibits the expression of genes involved in mitophagy in the stem cell of the human periodontal ligament. Molecules. 2019;24:3217. doi: 10.3390/molecules24183217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24183217</ArticleId><ArticleId IdType="pmc">PMC6767209</ArticleId><ArticleId IdType="pubmed">31487916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Zhao L., Xu M., Jiang P., Zhang K. Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway. Int. Immunopharmacol. 2024;134:112241. doi: 10.1016/j.intimp.2024.112241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2024.112241</ArticleId><ArticleId IdType="pubmed">38761782</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacoppo S., Rajan T.S., De Nicola G.R., Iori R., Rollin P., Bramanti P., Mazzon E. The isothiocyanate isolated from Moringa oleifera shows potent anti-inflammatory activity in the treatment of murine subacute Parkinson’s disease. Rejuvenation Res. 2017;20:50–63. doi: 10.1089/rej.2016.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/rej.2016.1828</ArticleId><ArticleId IdType="pubmed">27245199</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>